US Bancorp’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$95.4K Buy
1,642
+168
+11% +$9.12K ﹤0.01% 2410
2025
Q4
$68K Buy
1,474
+288
+24% +$12.9K ﹤0.01% 2560
2025
Q3
$42.7K Sell
1,186
-1,208
-50% -$40K ﹤0.01% 2748
2025
Q2
$77.8K Sell
2,394
-2,950
-55% -$96.7K ﹤0.01% 2564
2025
Q1
$202K Buy
5,344
+357
+7% +$28.5K ﹤0.01% 1991
2024
Q4
$408K Sell
4,987
-2,055
-29% -$204K ﹤0.01% 1607
2024
Q3
$805K Sell
7,042
-1,958
-22% -$176K ﹤0.01% 1243
2024
Q2
$680K Buy
9,000
+1,505
+20% +$102K ﹤0.01% 1303
2024
Q1
$512K Sell
7,495
-9,035
-55% -$626K ﹤0.01% 1491
2023
Q4
$1.04M Sell
16,530
-3,652
-18% -$190K ﹤0.01% 1095
2023
Q3
$1.03M Buy
20,182
+19,484
+2,791% +$961K ﹤0.01% 1039
2023
Q2
$34.9K Sell
698
-156
-18% -$7.39K ﹤0.01% 2699
2023
Q1
$32K Sell
854
-71
-8% -$3.01K ﹤0.01% 2744
2022
Q4
$44.4K Buy
925
+815
+741% +$32K ﹤0.01% 2602
2022
Q3
$3K Buy
+110
New +$2.79K ﹤0.01% 3749

Other funds holding PCVX